Gene expression inhibition of N-Myc downregulated gene 1 (NDRG1) monitoring and facilitation via transfectional transfer of NDRG1-siRNA constructs into- in vitro-cultured human glioblastoma cells
暂无分享,去创建一个
Matthias Guckenberger | Dirk Vordermark | Michael Flentje | Harun M. Said | Buelent Polat | Adrian Staab | Carsten Hagemann | Jelena Anacker | M. Flentje | M. Guckenberger | D. Vordermark | B. Polat | H. Said | C. Hagemann | Jelena Anacker | A. Staab
[1] M. Flentje,et al. Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] J. Brown,et al. Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies. , 2003, International journal of radiation oncology, biology, physics.
[3] T. Miyata,et al. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. , 2001, Genomics.
[4] Guoqiang Chen,et al. Comparative proteomic analysis of hypoxia‐treated and untreated human leukemic U937 cells , 2006, Proteomics.
[5] Y. Sadovsky,et al. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia. , 2007, American journal of obstetrics and gynecology.
[6] Jens Overgaard,et al. Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro , 2010, Acta oncologica.
[7] T. Iwaki,et al. Cellular Distribution of NDRG1 Protein in the Rat Kidney and Brain During Normal Postnatal Development , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[8] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[9] Yan Yan,et al. Downregulation of NDRG1 promotes invasion of human gastric cancer AGS cells through MMP-2 , 2011, Tumor Biology.
[10] L. Akslen,et al. Characteristics of human and rat glioma cells grown in a defined medium. , 1988, Anticancer research.
[11] M. Flentje,et al. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] Y. Fujii,et al. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[13] M. Westfall,et al. NDRG1 Is Necessary for p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.
[14] K. Shirouzu,et al. Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene Cap43 and the Y-box binding protein-1. , 2008, Current medicinal chemistry.
[15] N. Lévy,et al. NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement , 2007, Neuromuscular Disorders.
[16] Hakan Cangul,et al. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers , 2004, BMC Genetics.
[17] T. Shokati,et al. Effects of lovastatin on breast cancer cells: a proteo-metabonomic study , 2010, Breast Cancer Research.
[18] A. Merlo,et al. Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines. , 1999, Brain pathology.
[19] F. Shibasaki,et al. Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas , 2002, British Journal of Cancer.
[20] K. Watabe,et al. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. , 2008, Biochimica et biophysica acta.
[21] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[22] T. Tuschl,et al. Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. , 2002, Molecular interventions.
[23] Zhao-rui Yang,et al. Correlation between NDRG1 and PTEN expression in endometrial carcinoma , 2008, Cancer science.
[24] Maria Aparecida Nagai,et al. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients , 2011, Breast Cancer Research and Treatment.
[25] Z. Shao,et al. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis , 2010, Journal of Cancer Research and Clinical Oncology.
[26] Thomas Tuschl,et al. Expanding small RNA interference , 2002, Nature Biotechnology.
[27] J. A. Atarinagradin. Activation of hypoxia-inducible factor 1a: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor , 1997 .
[28] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[29] M. Flentje,et al. Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro. , 2008, Oncology reports.
[30] M. Kuwano,et al. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. , 2008, Oncology reports.
[31] L. Poellinger,et al. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[32] Guoqiang Chen,et al. NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells. , 2009, Leukemia research.
[33] D. Vordermark,et al. Evaluation of hypoxia-inducible factor-1α (HIF-1α) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: In vitro and xenograft studies , 2003 .
[34] M. Flentje,et al. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo. , 2009, Oncology reports.